Recommended for you






Program
PostDoc
Type
Position
Arrangement
Flexible
Funding
Grant Funded
Deadline
31 Aug 2026
Posted
09 Jun 2026
This postdoctoral researcher position is offered by Adam Mickiewicz University in Poznań, Poland, within the Laboratory of Stem Cell Biology and Regenerative Medicine, Institute of Molecular Biology and Biotechnology, Faculty of Biology. The role is part of the OPUS project UMO‑2024/53/B/NZ4/03103 funded by the National Science Center (NCN). The successful candidate will investigate pancreatic organoids derived from patients with type 2 diabetes, aiming to uncover disease mechanisms and develop novel cell‑ and gene‑based therapies.
The research program employs a cutting‑edge multi‑omics strategy. Candidates will differentiate human induced pluripotent stem cells into pancreatic beta cells, apply CRISPR/Cas9‑mediated genome editing, and generate three‑dimensional organoid cultures. Analyses will include single‑cell RNA sequencing to map transcriptional landscapes, quantitative proteomics and lipidomics to assess protein and metabolite profiles, functional assays to measure insulin secretion and glucose responsiveness, and microscopic imaging for structural validation. Mastery of every technique is not required, as the project encourages collaborative skill‑sharing and provides training opportunities.
The project is carried out in close collaboration with the team of Prof. Małgorzata Borowiak at Adam Mickiewicz University and with two research groups at the University of Helsinki, offering the possibility of short‑term internships abroad. The host laboratory is a young, dynamic, and efficiently functioning team that emphasizes cooperation, development, and mutual respect. Regular seminars, journal clubs, and joint meetings foster a stimulating scientific environment.
The appointment includes a fixed‑term full‑time employment contract with a gross monthly salary of PLN 8 987. Benefits comprise flexible working hours, funding for language learning, co‑financing of training and courses, additional days off for education, life insurance, pension plan, savings and investment fund, preferential loans, leisure‑time funding, subsidized children’s vacations, a “13th” salary, and a comprehensive healthcare package. The university also supports employees with disabilities and provides an atmosphere of respect and cooperation.
Applicants must hold or be about to obtain a PhD in molecular biology, cell biology, developmental biology, or biochemistry. Experience in multi‑omics, stem cell differentiation, pancreatic physiology, CRISPR/Cas9, or single‑cell RNA sequencing is considered advantageous, and fluency in English (both written and spoken) is required. The selection process involves a formal evaluation of submitted documents, possible requests for additional materials, interviews, and may include external reviews or teaching assignments. The competition committee begins work no later than 14 days after the application deadline.
To apply, send your CV, cover letter, and the required documents listed in the advertisement to [email protected]. The deadline for submission is 31 August 2026 (23:59 Europe/Warsaw). Selected candidates will be invited to an online interview. The position starts on 15 October 2026, with an initial contract of six months that can be extended based on performance until 13 February 2029.
Recommended for you





